ACE2 has previously been found to be associated with hypertension, stroke, dyslipidemia, cardiovascular diseases, and kidney diseases (Wang et al., 2014; Pan et al., 2018; Wu et al., 2018; Zhang et al., 2018). Here, ACE2 is linked to hypertensive disorder.